Rhumbline Advisers Reduces Stake in Infosys Limited (NYSE:INFY)

Rhumbline Advisers trimmed its stake in shares of Infosys Limited (NYSE:INFY - Free Report) by 6.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 715,723 shares of the technology company's stock after selling 45,950 shares during the quarter. Rhumbline Advisers' holdings in Infosys were worth $15,689,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the stock. Robeco Institutional Asset Management B.V. lifted its position in shares of Infosys by 68.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 24,339,983 shares of the technology company's stock worth $542,051,000 after purchasing an additional 9,923,744 shares during the period. Victory Capital Management Inc. raised its stake in Infosys by 6,071.1% in the third quarter. Victory Capital Management Inc. now owns 4,739,830 shares of the technology company's stock worth $105,556,000 after buying an additional 4,663,023 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new stake in Infosys in the third quarter worth about $36,039,000. Connor Clark & Lunn Investment Management Ltd. boosted its position in Infosys by 186.3% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,186,685 shares of the technology company's stock valued at $48,697,000 after acquiring an additional 1,422,814 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Infosys by 1,606.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,454,437 shares of the technology company's stock worth $32,143,000 after acquiring an additional 1,369,210 shares during the period. 16.20% of the stock is owned by hedge funds and other institutional investors.

Infosys Stock Performance

Shares of NYSE:INFY traded down $0.11 during trading on Tuesday, reaching $20.73. 9,214,992 shares of the stock traded hands, compared to its average volume of 9,967,978. Infosys Limited has a 52-week low of $16.04 and a 52-week high of $23.63. The stock has a market cap of $85.84 billion, a P/E ratio of 26.23, a price-to-earnings-growth ratio of 3.50 and a beta of 1.00. The stock has a 50-day moving average of $22.03 and a two-hundred day moving average of $22.30.

Infosys (NYSE:INFY - Get Free Report) last posted its earnings results on Thursday, January 16th. The technology company reported $0.19 EPS for the quarter, hitting analysts' consensus estimates of $0.19. Infosys had a return on equity of 31.60% and a net margin of 17.28%. During the same period last year, the business posted $0.18 earnings per share. Sell-side analysts expect that Infosys Limited will post 0.74 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on INFY. Hsbc Global Res upgraded Infosys from a "hold" rating to a "strong-buy" rating in a research note on Monday, December 9th. StockNews.com raised Infosys from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Guggenheim restated a "neutral" rating on shares of Infosys in a report on Friday, January 17th. Finally, HSBC raised Infosys from a "hold" rating to a "buy" rating in a research report on Monday, December 9th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $20.22.

Infosys Company Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.